Medicated Skin Care in France
1. EXECUTIVE SUMMARY
2. OPERATING ENVIRONMENT
2.1 OTC Registration and Classification
2.2 Vitamins and Dietary Supplements Registration and Classification
2.3 Advertising
2.4 Packaging and Labelling
2.5 Distribution
2.6 De-listing or De-reimbursement
2.7 Traditional Remedies
2.8 Homoeopathy
2.9 Generics
Table 1 Share of Generics: % of all Medicines Sold 2001-2005
2.10 Consumer Expenditure on Health Goods and Medical Services
Table 2 Consumer Expenditure on Health Goods and Medical Services 2000-2005
2.11 Life Expectancy
Table 3 Life Expectancy at Birth 2000-2005
3. OTC HEALTHCARE SALES
3.1 Market Performance
Table 4 Sales of OTC Healthcare by Sector: Value 2000-2005
Table 5 Sales of OTC Healthcare by Sector: % Value Growth 2000-2005
3.2 Switches
Summary 1 OTC Healthcare Switches 2004-2005
3.3 Key Trends and Developments
3.4 Competitive Environment
Table 6 OTC Healthcare Company Shares by Retail Value 2001-2005
Table 7 OTC Healthcare Brand Shares by Retail Value 2002-2005
3.5 Leading Company Profile: Arkopharma SA
Summary 2 Arkopharma SA Operational Indicators 2005
Table 8 Arkopharma SA: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.6 Leading Company Profile: Boehringer Ingelheim France SAS
Summary 3 Boehringer Ingelheim France SAS Operational Indicators 2005
Table 9 Boehringer Ingelheim France SAS: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.7 Leading Company Profile: Laboratoires Martin-Johnson & Johnson-MSD SAS
Summary 4 Laboratoires Martin Johnson & Johnson Operational Indicators 2005
Table 10 Laboratoires Martin-Johnson & Johnson-MSD SAS: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.8 Leading Company Profile: Pierre Fabre SA, Laboratoires
Summary 5 Pierre Fabre SA, Laboratoires Operational Indicators 2005
Summary 6 Pierre Fabre SA, Laboratoires: Production Statistics 2005
Table 11 Pierre Fabre SA, Laboratoires: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.9 Leading Company Profile: Laboratoires Juva Sant
Summary 7 Laboratoires Juva Sant Operational Indicators 2005
Summary 8 Laboratoires Juva Sant: Production Statistics 2005
Table 12 Juva Sant, Laboratoires: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.10 Leading Company Profile: Laboratoires Roche Nicholas SAS
Summary 9 Laboratoires Roche Nicholas SAS Operational Indicators 2003
Summary 10 Laboratoires Roche Nicholas SAS: Breakdown of Production by Value 2003
Table 13 Laboratoires Roche Nicholas SAS: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.11 Leading Company Profile: Pfizer Sant Grand Public
Summary 11 Pfizer Sant Grand Public Operational Indicators 2004
Table 14 Pfizer Sant Grand Public: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.12 Leading Company Profile: Laboratoires UPSA
Summary 12 UPSA, Laboratoires Operational Indicators 2004
Table 15 UPSA, Laboratoires: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.13 Leading Company Profile: Sanofi Aventis France
Summary 13 Sanofi Aventis France Operational Indicators 2004
Table 16 Sanofi Aventis France: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.14 Leading Company Profile: Thraplix SA
Summary 14 Thraplix SA Operational Indicators 2005
Table 17 Thraplix SA: Shares of OTC Healthcare by Subsector by Retail Value 2001-2005
3.15 Retail Distribution
Table 18 Sales of OTC Healthcare by Distribution Format: % Analysis 2000/2005
Table 19 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2005
3.16 Retailer Activity and Private Label Trends
Table 20 Penetration of Private Label by Sector 2001-2005
3.17 Forecast Market Performance
Table 21 Forecast Sales of OTC Healthcare by Sector: Value 2005-2010
Table 22 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2005-2010
4. MEDICATED SKIN CARE SALES
4.1 Sector Performance
Table 23 Sales of Medicated Skin Care by Subsector: Value 2000-2005
Table 24 Sales of Medicated Skin Care by Subsector: % Value Growth 2000-2005
Table 25 Medicated Skin Care Company Shares by Retail Value 2001-2005
Table 26 Medicated Skin Care Brand Shares by Retail Value 2002-2005
Table 27 Forecast Sales of Medicated Skin Care by Subsector: Value 2005-2010
Table 28 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2005-2010
4.2 New Product Developments
Summary 15 Medicated Skin Care: New Product Launches 2005
4.3 Medicated Skin Care by Herbal/Standard Split
Table 29 Herbal vs Standard Medicated Skin Care 2000/2005
4.4 Acne Treatments Brand Shares
Table 30 Acne Treatments Brand Shares by Retail Value 2002-2005
4.5 Hair Loss Treatments Brand Shares
Table 31 Hair Loss Treatments Brand Shares by Retail Value 2002-2005
5. DEFINITIONS
